Korean J Intern Med.
2015 Jul;30(4):550-553. 10.3904/kjim.2015.30.4.550.
Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection
- Affiliations
-
- 1Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea. yhimhy@jbnu.ac.kr
- 2Research Institute of Clinical Medicine, Chonbuk National University Hospital, Jeonju, Korea.
- 3Department of Nursing, Wonkwang University School of Medicine, Iksan, Korea.
- KMID: 2366019
- DOI: http://doi.org/10.3904/kjim.2015.30.4.550
Abstract
- No abstract available.
MeSH Terms
-
Adult
Antineoplastic Agents/*adverse effects
Antitubercular Agents/therapeutic use
Biopsy
Female
Gastrointestinal Stromal Tumors/*drug therapy/pathology/surgery
Humans
Imatinib Mesylate/*adverse effects
Lung Diseases, Interstitial/*chemically induced/diagnosis
Mycobacterium tuberculosis/*isolation & purification
Protein Kinase Inhibitors/*adverse effects
Rectal Neoplasms/*drug therapy/pathology/surgery
Tomography, X-Ray Computed
Tuberculosis, Pulmonary/diagnosis/drug therapy/*microbiology
Antineoplastic Agents
Antitubercular Agents
Imatinib Mesylate
Protein Kinase Inhibitors
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Imatinib-Mesylate Induced Interstitial Pneumonitis in Two CML Patients
- Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis
- A Case of Lichenoid Drug Eruption Associated with Imatinib Mesylate
- Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
- Imatinib Mesylate-Induced Hyperpigmentation of the Nose and Palate
